Bruker Corporation to Present at Upcoming Investor Conferences
Bruker (Nasdaq: BRKR) has announced its participation in two upcoming investor conferences: the 2024 Jefferies Global Healthcare Conference on June 6, 2024, in New York, NY, and the 45th Annual Goldman Sachs Global Healthcare Conference on June 12, 2024, in Miami, FL.
The company's top executives, including Chairman and CEO Frank Laukien and CFO Gerald Herman, will deliver presentations. Live audio webcasts of both events will be available on Bruker's Investor Relations website.
Replays of the presentations will also be accessible for at least 30 days post-event.
- Bruker 's participation in high-profile conferences may attract investor interest.
- Top executives, including the CEO and CFO, will be presenting, which can add credibility and trust.
- Webcasts and replays offer transparency and accessibility to a broader audience of potential investors.
- The press release lacks specific details about the content and agenda of the presentations.
- No new product launches or financial updates are mentioned, which may leave investors wanting more substantive information.
2024 Jefferies Global Healthcare Conference,
Thursday, June 6, 2024, at 7:30 a.m. Eastern Time
Frank Laukien, Chairman, President and Chief Executive Officer
Juergen Srega, President, Bruker CALID Group
45th Annual Goldman Sachs Global Healthcare Conference,
Wednesday, June 12, 2024, at 11:20 a.m. Eastern Time
Gerald Herman, Executive Vice President and Chief Financial Officer
Live audio webcasts of the presentations will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. Replays of the presentations will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the event and will be available for at least 30 days following the presentations.
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240531744683/en/
Justin Ward
Sr. Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 313-5800
E: Investor.Relations@bruker.com
Source: Bruker Corporation
FAQ
When will Bruker present at the 2024 Jefferies Global Healthcare Conference?
Who will represent Bruker at the 45th Annual Goldman Sachs Global Healthcare Conference?
Where can I access the live audio webcasts of Bruker 's presentations?
How long will the replays of Bruker's presentations be available?
